Factors affecting recurrence in node-negative advanced gastric cancer

Journal of Gastroenterology and Hepatology (Australia)

Volumn 24, Issue 9, 2009, Pages 1522-1526

  Huang, Kuo Hung ^a   Chen, Jen Hao ^a   Wu, Chew Wun ^a   Lo, Su Shun ^a   Hsieh, Mao Chih ^a   Li, Anna F Y ^b   Lui, Win Yiu ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Advanced gastric adenocarcinoma; Node negative; R0 resection; Recurrent pattern

Indexed keywords

ADVANCED CANCER; AGED; ARTICLE; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER SIZE; CANCER SURGERY; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA;

ADENOCARCINOMA; AGED; FEMALE; GASTRECTOMY; HEMATOLOGIC NEOPLASMS; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM SEEDING; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; STOMACH NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME;

EID: 69949151458     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2009.05844.x     Document Type: Article

References (23)

1. Siewert JR, Bottcher K, Stein HJ, Roder JD. Relevant prognostic factors in gastric cancer. Ten-year results of the German gastric cancer study. Ann. Surg. 1998 228 : 449 461.
2. Kim JP, Kim YW, Yang HK, Noh DY. Significant prognostic factors by multivariate analysis of 3926 gastric cancer patients. World J. Surg. 1994 18 : 872 877.
3. Wu CW, Hsieh MC, Lo SS et al. Prognostic indicators for survival after curative resection for patients with carcinoma of the stomach. Dig. Dis. Sci. 1997 42 : 1265 1269.
4. Wu CW, Hsieh MC, Lo SS, Tsay SH, Lui WY, P'eng FK. Relation of number of positive lymph nodes to the prognosis of patients with primary gastric adenocarcinoma. Gut 1996 38 : 525 527.
5. Sarela AI, Turnbull AD, Coit DG, Klimstra D, Brennan MF, Karpeh MS. Accurate lymph node staging is of greater prognostic importance than subclassification of the T2 category for gastric adenocarcinoma. Ann. Surg. Oncol. 2003 10 : 783 791.
6. Hyung WJ, Noh SH, Yoo CH et al. Prognostic significance of metastatic lymph node ratio in T3 gastric cancer. World J. Surg. 2001 26 : 323 329.
7. Maehara Y, Tomoda M, Tomisaki S et al. Surgical treatment and outcome for node-negative gastric cancer. Surgery 1997 121 : 633 639.
8. Adachi Y, Mori M, Maehara Y, Kitano S, Sugimachi K. Prognostic factors of node-negative gastric carcinoma: univariate and multivariate analyses. J. Am. Coll. Surg. 1997 184 : 373 377.
9. Bruno L, Nesi G, Montinaro F et al. Clinicopathologic characteristics and outcome indicators in node-negative gastric cancer. J. Surg. Oncol. 2000 74 : 30 2.
10. Hyung WJ, Lee JH, Choi SH, Min JS, Noh SH. Prognostic impact of lymphatic and/or blood vessel invasion in patients with node-negative advanced gastric cancer. Ann. Surg. Oncol. 2002 9 : 562 567.
11. Kooby DA, Suriawinata A, Klimstra DS, Brennan MF, Karpeh MS. Biologic predictors of survival in node-negative gastric cancer. Ann. Surg. 2003 237 : 828 837.
12. Marrelli D, Roviello F, de Manzoni G et al. Different patterns of recurrence in gastric cancer depending on Lauren's histological type: longitudinal study. World J. Surg. 2002 26 : 1160 1165.
13. Wu CW, Lo SS, Shen KH et al. Incidence and factors associated with recurrence patterns after intended curative surgery for gastric cancer. World J. Surg. 2003 27 : 153 158.
14. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma, 2nd English edition. Gastric Cancer 1998 1 : 10 24.
15. Chen HC, Chu RY, Hsu PN et al. Loss of E-cadherin expression correlates with poor differentiation and invasion into adjacent organs in gastric adenocarcinoma. Cancer Lett. 2003 201 : 97 106.
16. Kopfstein L, Christofori G. Metastasis: cell-autonomous mechanisms versus contributions by tumor microenviroment. Cell. Mol. Life Sci. 2006 63 : 449 468.
17. Yu P, Rowley DA, Fu YX, Schreiber H. The role of stroma in immune recognition and destruction of well-estabished solid tumors. Curr. Opin. Immunol. 2006 18 : 226 231.
18. Hofmeister V, Vetter C, Schrama D, Brocker EB, Becker JC. Tumor stroma-associated antigens for anti-cancer immunotherapy. Cancer Immunol. Immunother. 2006 55 : 481 494.
19. Yokota T, Ishiyama S, Saito T et al. Is tumor size a prognostic indicator for gastric carcinoma? Anticancer Res. 2002 22 : 3673 3677.
20. Saito H, Osaki T, Murakami D et al. Macroscopic tumor size as a simple prognostic indicator in patients with gastric cancer. Am. J. Surg. 2006 192 : 296 300.
21. Yasuda K, Adachi Y, Shiraishi N, Inomata M, Takeuchi H, Kitano S. Prognostic effect of lymph node micrometastasis in patients with histologically node-negative gastric cancer. Am. J. Surg. Oncol. 2002 9 : 771 774.
22. Harrison LE, Choe JK, Goldstein M, Meridian A, Kim SH, Clarke K. Prognostic significance of immunohistochemical micrometastases in node negative gastric cancer patients. J. Surg. Oncol. 2000 73 : 153 157.
23. Wu CW, Hsiung CA, Lo SS et al. Nodal dissection for patients with gastric cancer: a randomised controlled trial. Lancet Oncol. 2006 7 : 309 315.